BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1711148)

  • 21. Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.
    Balzarini J; Pelemans H; Aquaro S; Perno CF; Witvrouw M; Schols D; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 Aug; 50(2):394-401. PubMed ID: 8700148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
    Debyser Z; Pauwels R; Baba M; Desmyter J; De Clercq E
    Mol Pharmacol; 1992 May; 41(5):963-8. PubMed ID: 1375320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1992 Jan; 35(2):337-45. PubMed ID: 1732552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Suppression of the human immunodeficiency virus in cultured cells by 5'-phosphites of 3'-azido-2',3'-dideoxynucleosides].
    Karamov EV; Lukashov VV; Tarusova NB; Kornilaeva GV; Rodova MA; Kukhanova MK; Kraevskiĭ AA
    Mol Biol (Mosk); 1990; 24(6):1695-701. PubMed ID: 1710021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
    Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
    McMahon JB; Buckheit RW; Gulakowski RJ; Currens MJ; Vistica DT; Shoemaker RH; Stinson SF; Russell JD; Bader JP; Narayanan VL; Schultz RJ; Brouwer WG; Felauer EE; Boyd MR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):298-305. PubMed ID: 8558446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
    Tanaka H; Baba M; Ubasawa M; Takashima H; Sekiya K; Nitta I; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1991 Apr; 34(4):1394-9. PubMed ID: 2016715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.
    Balzarini J; Pelemans H; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 May; 49(5):882-90. PubMed ID: 8622638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-HIV-1 activity of novel 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones.
    Danel K; Pedersen EB; Nielsen C
    J Med Chem; 1998 Jan; 41(2):191-8. PubMed ID: 9457243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.
    Baba M; Shigeta S; Yuasa S; Takashima H; Sekiya K; Ubasawa M; Tanaka H; Miyasaka T; Walker RT; De Clercq E
    Antimicrob Agents Chemother; 1994 Apr; 38(4):688-92. PubMed ID: 7518216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HEPT and its related compounds as anti-HIV agents].
    Miyasaka T; Tanaka H; Baba M
    Nihon Rinsho; 1993 Sep; 51 Suppl():200-6. PubMed ID: 7505847
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Inouye N; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1995 Jul; 38(15):2860-5. PubMed ID: 7636846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives with potential anti-HIV activity.
    Isono Y; Sakakibara N; Ordonez P; Hamasaki T; Baba M; Ikejiri M; Maruyama T
    Antivir Chem Chemother; 2011 Oct; 22(2):57-65. PubMed ID: 21984685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
    Puig-de-la-Bellacasa R; Giménez L; Pettersson S; Pascual R; Gonzalo E; Esté JA; Clotet B; Borrell JI; Teixidó J
    Eur J Med Chem; 2012 Aug; 54():159-74. PubMed ID: 22652226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of the acquired immune deficiency syndrome (AIDS): non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptase.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():83-9. PubMed ID: 1726686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon.
    Ito M; Baba M; Shigeta S; De Clercq E; Walker RT; Tanaka H; Miyasaka T
    Antiviral Res; 1991 May; 15(4):323-30. PubMed ID: 1683214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].
    Mitsuya H
    Nihon Rinsho; 1991 Sep; 49(9):2062-9. PubMed ID: 1720470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.